Insider Sale: Director at $XPRO Sells 2,712 Shares

Eileen Goss Whelley, a director at $XPRO, sold 2,712 shares on June 3rd, 2025, for approximately $22,168, representing 5.7% of their holdings. Over the last six months, insider trading activity has been balanced with two purchases and two sales, while Q1 2025 saw institutional investors showing mixed sentiment, with T. Rowe Price reducing its stake by 36.6% and Earnest Partners LLC increasing its position by 60.0%; Barclays issued an "Overweight" rating on May 7th, 2025.

Analysis

A director at $XPRO, Eileen Goss Whelley, recently sold 2,712 shares, constituting 5.7% of her holdings in that class of stock, for an estimated $22,168, leaving her with 44,909 shares. This specific sale is part of a balanced pattern of insider activity over the past six months, which includes two purchases and two sales. Notably, the President & CEO, Michael Jardon, made a substantial purchase of 45,200 shares valued at approximately $493,132, contrasting with the smaller director sale. Institutional holdings data from Q1 2025 reveals a mixed sentiment, with 112 investors adding $XPRO shares and 109 decreasing positions. Significant institutional movements include T. Rowe Price Investment Management reducing its stake by 36.6% (4,069,103 shares) and Earnest Partners LLC increasing its position by 60.0% (2,678,489 shares). Other large reductions were seen from Encompass Capital Advisors (-74.3%), Jennison Associates (-63.4%), and Marshall Wace, LLP (-76.3%) in Q1 2025, while Westfield Capital Management and Loomis Sayles & Co completely exited their positions in Q4 2024. On the analyst front, Barclays issued an "Overweight" rating on $XPRO on May 7th, 2025, and is the sole firm noted with a recent buy rating, against zero sell ratings.

Key Decisions for Investors

• Investors should weigh the director's modest sale against the significantly larger recent purchase by the CEO, which could indicate stronger confidence from top leadership.
• The mixed institutional investor activity, characterized by substantial divestments from several large funds alongside a significant new accumulation by Earnest Partners, warrants careful monitoring of subsequent quarterly filings to discern a clearer trend.
• Consider the positive "Overweight" rating from Barclays as a potentially bullish signal, but balance this against the observed institutional selling pressure and the isolated nature of the recent positive analyst coverage.